HUTCHMED (China) Limited (HMDCF) Financials

HMDCF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.8 billion 501.8 million
June 30, 2025 1.8 billion 534.0 million
March 31, 2025 1.8 billion 534.0 million
Dec. 31, 2024 1.3 billion 502.3 million

HMDCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 -41.1 million 3.8 million
March 31, 2025 -41.1 million 3.8 million
Dec. 31, 2024 16.3 million 5.1 million

HMDCF Net Income

No data available :(

HMDCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 1.4 billion 70.0 million 4.7 million
June 30, 2025 1.4 billion 96.6 million 7.3 million
March 31, 2025 1.4 billion 71.0 million 7.3 million
Dec. 31, 2024 836.1 million 63.5 million 7.0 million

HMDCF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 859.5 million
June 30, 2025 872.6 million
March 31, 2025 872.6 million
Dec. 31, 2024 873.1 million

HMDCF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - - - -
June 30, 2025 4.6 million 36.0 million 20.8 million 6.9 million
March 31, 2025 4.6 million 36.0 million 20.8 million 6.9 million
Dec. 31, 2024 3.9 million 59.1 million 27.6 million 24.3 million

HMDCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - -
June 30, 2025 138.8 million 83.8 million
March 31, 2025 138.8 million 83.8 million
Dec. 31, 2024 162.3 million 190.4 million

HMDCF

Price: $2.16

52 week price:
2.16
3.82

Earnings Per Share: 0.53 USD

P/E Ratio: 5.32

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 1.9 billion

Links: